Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | OPRK1 | P41145 | 2/20 | 0.43 |
| ▸ | CCKAR | P32238 | 17/20 | 0.42 |
| ▸ | CCKBR | P32239 | 14/20 | 0.42 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.39 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25969517 | 0.90 | CCKAR (0.40) | OPRK1CCKARCCKBROPRL1 | |
| SCHEMBL25753191 | 0.88 | CCKAR (0.40) | OPRK1CCKARCCKBROPRL1 | |
| SCHEMBL27268254 | 0.85 | OPRL1 (0.43) | OPRK1OPRL1 | |
| SCHEMBL25881766 | 0.85 | OPRL1 (0.42) | OPRL1 | |
| SCHEMBL25764635 | 0.85 | OPRL1 (0.42) | OPRL1 | |
| SCHEMBL25649781 | 0.85 | OPRL1 (0.41) | OPRK1OPRL1 | |
| SCHEMBL25748810 | 0.84 | OPRL1 (0.41) | OPRK1OPRL1 | |
| SCHEMBL26171361 | 0.84 | OPRK1 (0.50) | OPRK1OPRL1 | |
| SCHEMBL20345222 | 0.84 | CCKAR (0.43) | OPRK1CCKARCCKBROPRL1 | |
| SCHEMBL25649780 | 0.84 | OPRK1 (0.48) | OPRK1CCKARCCKBROPRL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230212182-A1 | ANTI-TUMOR COMPOUND AND PREPARATION METHOD AND USE THEREOF | DUALITY BIOLOGICS (SUZHOU) CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230212182-A1 | ANTI-TUMOR COMPOUND AND PREPARATION METHOD AND USE THEREOF | RCC2, REN, VHL | OPRK1 2298/4885CCKAR 876/4885CCKBR 1459/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.